Rapport Therapeutics, Inc. RAPP Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $78.06M+35.5% | $52.65M-7.3% | $251.36M+539% | $55.07M-50.0% | $57.6M-22.4% | ||
| $398.73M+75.1% | $437.89M— | $261.67M— | $205.38M— | $227.78M— | ||
| —— | —— | —— | —— | —— | ||
| $484.7M+66.6% | $498.56M— | $520.66M— | $270.24M— | $290.97M— | ||
| $2.52M-26.0% | $2.98M— | $3.12M— | $3.17M— | $3.4M— | ||
| $497.6M+64.7% | $512.43M— | $535.32M— | $285.5M— | $302.05M— | ||
| $17.16M+135% | $12.74M+217% | $10.5M+130% | $8.59M+122% | $7.29M— | ||
| $17.9M+90.7% | $19.05M— | $14.32M— | $11.88M— | $9.38M— | ||
| $26.09M+60.8% | $27.78M— | $23.71M— | $21.98M— | $16.22M— | ||
| $48K+29.7% | $48K— | $48K— | $37K— | $37K— | ||
| -$255.09M-72.6% | -$235.23M— | -$201.47M— | -$174.54M— | -$147.81M— | ||
| $471.51M+65.0% | $484.65M+58.7% | $511.62M+58.3% | $263.51M-21.8% | $285.84M+821% | ||
| $497.6M+64.7% | $512.43M— | $535.32M— | $285.5M— | $302.05M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Rapport Therapeutics, Inc.'s total assets?
- Rapport Therapeutics, Inc. (RAPP) holds $497.6M in total assets, up 64.7% year over year.
- How much debt does Rapport Therapeutics, Inc. have?
- Rapport Therapeutics, Inc. carries $10.8M in total debt against $471.5M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Rapport Therapeutics, Inc. have?
- Rapport Therapeutics, Inc. holds $78.1M in cash and equivalents.
- Can Rapport Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 27.08 — current assets exceed current liabilities.
- Where does Rapport Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Rapport Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.